AVP AVPI

  1. All
  2. Commentary
  3. Headlines
    1. Goldman: Every client asking about the same four things

      Headlines

      Tue, 14 Oct 2014

      of S&P 500 names capturing two or more of Kostin's themes: GT , GM , PCLN , AMZN , CMCSA , LOW , DG , TSN , ADM , CVS , AVP , WAG , PXD , HAL , JPM , BAC , SCHW , PNC , MS , C , GNW , LNC , MET , THC , AET , UNH , ESRX , HUM , WLP , BIIB , GILD , DAL

    2. The Elephant In The Room: Why The FTC Is Taking So Long To Investigate Herbalife

      Headlines

      Tue, 14 Oct 2014

      By Robert FitzPatrick : On March 12, 2014, Herbalife (NYSE: HLF ) announced it received a Civil Investigative Demand from the Federal Trade Commission, FTC. This FTC action was generally viewed as being prompted, at least in part, by the critical information published by the hedge fund, Pershing ...

    3. Avanir presents AVP -923 Phase 2 data at neurology meeting

      Headlines

      Mon, 13 Oct 2014

      from its Phase 2 clinical trial evaluating AVP -923 for the treatment of agitation in ..... mean reduction from baseline of 47% for AVP -923 compared to 22% for placebo in Stage ..... vs 6.7%, respectively in Stage 2. AVP -923 is a combination of two well-characterized

    4. Investors swap tech and momo favorites for staples and dividend-payers

      Headlines

      Fri, 10 Oct 2014

      peeling off some tech and momentum favorites. The partial list below represents stocks up at least 1% on the day with a dividend yield of over 2%. Back in favor: AVP , KO , MO , RAI , BUD , PF , BGS , DPS , CPB , LO , DF . Post your comment!

    5. Active vs. Passive Investing: A Bottom Line

      Headlines

      Tue, 7 Oct 2014

      active over passive. The higher the relative breadth percentage, the greater the tendency for active to outperform passive. AvP 3yr = excess return of active over passive during rolling 3-year periods. Source: Haver Analytics, Morningstar, Fidelity

    6. All Pop And No Sizzle Or Is Avanir Going Higher From Here?

      Headlines

      Wed, 17 Sep 2014

      previous session at 6.74 and closing on the 15th at 12.40 on the announcement of a successful phase-II trial of their drug AVP -923 , which has until now been used to treat patients with pseudobulbar affect under the brand name Neudexta, for use in patients

    7. Proft taking after Avanir up move

      Headlines

      Tue, 16 Sep 2014

      Avanir Pharmaceuticals (NASDAQ: AVNR ) is off 6% premarket on robust volume as traders begin to take profits from yesterday's ultra-bullish 85% jump on turnover of ~89M shares in response to positive Phase 2 trial results for AVP -923. Post your comment!

    8. Concert Pharma rides Avanir's coattails

      Headlines

      Mon, 15 Sep 2014

      pop after it reported positive Phase 2 results for AVP -923. Concert's license agreement with Avanir pertains ..... modified dextromethorphan (d-DM) which is what AVP -786 is based on. AVP -923 is a combination of dextromethorphan and quinidine

    9. Avanir skyrockets premarket on trial results

      Headlines

      Mon, 15 Sep 2014

      response to its announcement of positive results from its Phase 2 trial evaluating AVP -923 for the treatment of agitation in patients with Alzheimer's disease. AVP -923 achieved the primary endpoint of a statistically significant reduction in

    10. Herbalife Field Report: Nutrition Clubs

      Headlines

      Sat, 13 Sep 2014

      By Rogier van Vlissingen : Herbalife (NYSE: HLF ) continues to amaze. The stock has been sliding on low volumes for quite a while, then we had an acceleration in volume for a few days and a continuing slide, with two 52-week lows posted on successive days. At the open on 9/11, it went up a bit, ...

    « Prev12Next »
    Content Partners